Association of <i>IDH1</i> mutations with survival and recurrence in resected intrahepatic cholangiocarcinoma received or not received adjuvant chemotherapy
Shaolai Zhou(Fudan University), Zhiqiang Hu(Jiangsu University), Zhihuan Zhou(Fudan University), Jixue Zou(Fudan University), Jing Pu(Fudan University), Jian Zhou(Fudan University), Chubin Luo(Fudan University), Ning Li(Fudan University), Jia Li(Fudan University), Yuhang Ye(Sun Yat-sen University), Rongqi Sun(Fudan University)
Cited by 0
Related Papers
<p>Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China</p>
|Cancer Management and Research|2020|39
Modified Chaihu Shugan Powder for Functional Dyspepsia: Meta-Analysis for Randomized Controlled Trial
|Evidence-based Complementary and Alternative Medicine|2013|27
Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study
|Cancer Medicine|2020|24
Image-mode performance characterisation of a positron emission tomography subsystem designed for Biology-guided radiotherapy (BgRT)
|British Journal of Radiology|2022|20
Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors
|Frontiers in Immunology|2024|14